The markets traded mixed during the with the Dow rising 39 points to 11,562 as investors digested the bankruptcy filing of American Airlines parent AMR. Nasdaq lost 15 points to 2512.
On the upside
Inhibitex (Nasdaq: INHX) reported upbeat results from an ongoing Phase1b clinical trial of its hepatitis C treatment INX-189 and announced plans to expand drug studies of INX-189.
Russian Standard Vodka acquired a 9.9% stake in rival Central European Distribution (Nasdaq: CEDC).
Shares of Cemex (NYSE: CX) continued to recover as bargain hunters snapped up shares of the cement maker.
On the downside
American Airlines parent AMR (NYSE: AMR) filed for Chapter 11 bankruptcy protection.
Shares of Regions Financial (NYSE: RF) fell as European leaders continued to negotiate details of the financial rescue plan.
Falling home prices weighed down shares of mortgage insurer Radian Group (Nasdaq: RDN).
In the broad market, advancing issues edged out decliners by a margin of nearly 10 to 9 on the NYSE while decliners outpaced advancers by a margin of more than 7 to 5 on Nasdaq. The Russell 2000 which tracks small cap stocks eased a point to 696.
